Cell and gene therapy manufacturing companies find success in North Carolina

The year was 1993 and R. Jude Samulski, Ph.D., was one of the leading scientists in the emerging gene therapy field when he decided to join the research team at the University of North Carolina at Chapel Hill. It was there he brought his adeno-associated virus (AAV) technology to life, effectively making the Research Triangle Region one of the birthplaces of cell and gene therapy. Fast forward to 2020 and the industry continues to grow and thrive in the region’s strong life science ecosystem,…